Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,115 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Knee osteoarthritis and all-cause mortality: the Wuchuan Osteoarthritis Study.
Liu Q, Niu J, Huang J, Ke Y, Tang X, Wu X, Li R, Li H, Zhi X, Wang K, Zhang Y, Lin J. Liu Q, et al. Among authors: zhi x. Osteoarthritis Cartilage. 2015 Jul;23(7):1154-7. doi: 10.1016/j.joca.2015.03.021. Epub 2015 Mar 25. Osteoarthritis Cartilage. 2015. PMID: 25819581 Free article.
Final overall survival results from a randomised, phase III study of erlotinib versus chemotherapy as first-line treatment of EGFR mutation-positive advanced non-small-cell lung cancer (OPTIMAL, CTONG-0802).
Zhou C, Wu YL, Chen G, Feng J, Liu XQ, Wang C, Zhang S, Wang J, Zhou S, Ren S, Lu S, Zhang L, Hu C, Hu C, Luo Y, Chen L, Ye M, Huang J, Zhi X, Zhang Y, Xiu Q, Ma J, Zhang L, You C. Zhou C, et al. Among authors: zhi x. Ann Oncol. 2015 Sep;26(9):1877-1883. doi: 10.1093/annonc/mdv276. Epub 2015 Jul 3. Ann Oncol. 2015. PMID: 26141208 Free article. Clinical Trial.
Quality of life (QoL) analyses from OPTIMAL (CTONG-0802), a phase III, randomised, open-label study of first-line erlotinib versus chemotherapy in patients with advanced EGFR mutation-positive non-small-cell lung cancer (NSCLC).
Chen G, Feng J, Zhou C, Wu YL, Liu XQ, Wang C, Zhang S, Wang J, Zhou S, Ren S, Lu S, Zhang L, Hu CP, Hu C, Luo Y, Chen L, Ye M, Huang J, Zhi X, Zhang Y, Xiu Q, Ma J, Zhang L, You C. Chen G, et al. Among authors: zhi x. Ann Oncol. 2013 Jun;24(6):1615-22. doi: 10.1093/annonc/mdt012. Epub 2013 Mar 1. Ann Oncol. 2013. PMID: 23456778 Free article. Clinical Trial.
Pretreatment hemoglobin level as a predictor to evaluate the efficacy of immune checkpoint inhibitors in patients with advanced non-small cell lung cancer.
Zhang Z, Zhang F, Yuan F, Li Y, Ma J, Ou Q, Liu Z, Yang B, Wang L, Tao H, Zhang S, Li X, Zhi X, Ge X, Bao H, Wu X, Hu Y, Wang J. Zhang Z, et al. Among authors: zhi x. Ther Adv Med Oncol. 2020 Nov 5;12:1758835920970049. doi: 10.1177/1758835920970049. eCollection 2020. Ther Adv Med Oncol. 2020. PMID: 33224276 Free PMC article.
Study on the mechanism of regulating the hypothalamic cortical hormone releasing hormone/corticotropin releasing hormone type I receptor pathway by vibro-annular abdominal massage under the brain-intestine interaction in the treatment of insomnia.
Zhang Y, Cong D, Liu P, Zhi X, Shi C, Zhao J, Zhang H. Zhang Y, et al. Among authors: zhi x. Medicine (Baltimore). 2021 May 14;100(19):e25854. doi: 10.1097/MD.0000000000025854. Medicine (Baltimore). 2021. PMID: 34106630 Free PMC article.
Dynamics of Serum Tumor Markers Can Serve as a Prognostic Biomarker for Chinese Advanced Non-small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors.
Zhang Z, Yuan F, Chen R, Li Y, Ma J, Yan X, Wang L, Zhang F, Tao H, Guo D, Huang Z, Zhang S, Li X, Zhi X, Ge X, Hu Y, Wang J. Zhang Z, et al. Among authors: zhi x. Front Immunol. 2020 Jun 10;11:1173. doi: 10.3389/fimmu.2020.01173. eCollection 2020. Front Immunol. 2020. PMID: 32587591 Free PMC article.
[Research Progress of Circular RNA in Lung Cancer].
Ge X, Zhang Z, Zhi X, Wang J. Ge X, et al. Among authors: zhi x. Zhongguo Fei Ai Za Zhi. 2020 Dec 20;23(12):1095-1100. doi: 10.3779/j.issn.1009-3419.2020.102.38. Zhongguo Fei Ai Za Zhi. 2020. PMID: 33357317 Free PMC article. Review. Chinese.
Immunotherapy beyond progression in patients with advanced non-small cell lung cancer.
Ge X, Zhang Z, Zhang S, Yuan F, Zhang F, Yan X, Han X, Ma J, Wang L, Tao H, Li X, Zhi X, Huang Z, Hofman P, Prelaj A, Banna GL, Mutti L, Hu Y, Wang J. Ge X, et al. Among authors: zhi x. Transl Lung Cancer Res. 2020 Dec;9(6):2391-2400. doi: 10.21037/tlcr-20-1252. Transl Lung Cancer Res. 2020. PMID: 33489801 Free PMC article.
1,115 results